Allscripts-Misys Healthcare Solutions is about to drop the "Misys" part, as the Chicago-based company has agreed to a $1.3 billion all-stock takeover of Eclipsys. As part of the deal, Misys plc will ...

Allscripts and Eclipsys expect the transaction to be completed promptly after all other conditions to the merger are satisfied, including the completion of the sale of no less than 25 million shares ...

Hospitals and doctors are slowly -- but finally! -- getting the idea that they need to work more closely together to improve quality and cut costs. Unsurprisingly, healthcare IT -- especially ...

In June, one of the biggest mergers of EHR vendors in quite some time was the talk of the healthcare IT world. "Any time a business decision is client-driven, it's much more likely to be successful," ...

Leadership and execution are key to the success of the Allscripts-Eclipsys merger, according to the Allscripts customers, who say the merger presents both challenges and opportunities. Chicago-based ...

Part one of a two-part series: Allscripts-Misys Healthcare Solutions, Chicago, a developer of electronic health records systems for ambulatory-care physicians, will borrow most of the $577 million or ...

One Company to Deliver a Single Patient Record "Both Eclipsys and Allscripts share a vision of a connected system of health in which critical information follows the patient and informs all providers ...

Allscripts said it is buying Eclipsys in an all-stock deal that will take out its British investors, Misys. The idea is that after Allscripts shares are used for Eclipsys, in a deal worth $1.3 billion ...

LONDON/NEW YORK (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for electronic ...

Allscripts is one of the largest companies focused exclusively on healthcare information technology, with over 5,500 employees and combined 2009 pro forma revenues of approximately $1.2 billion. It ...

Allscripts and Eclipsys expect the transaction to be completed promptly after all other conditions to the merger are satisfied, including the completion of the sale of no less than 25 million shares ...